Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flaminal
- Development stage
- Phase 4
- Lead developer
- Flen Health
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Flaminal is an advanced enzyme alginogel wound dressing developed and marketed by Flen Health. It utilizes a biotechnological approach to wound care by incorporating two active antimicrobial enzymes: glucose oxidase and lactoperoxidase. These enzymes work synergistically within the gel matrix to generate reactive oxygen species that eliminate bacteria, providing broad-spectrum antimicrobial protection without damaging healthy tissue. Flaminal is available in two formulations, Hydro and Forte, which are tailored to manage different levels of wound exudate. It is indicated for the treatment of various acute and chronic wounds, including infected wounds, diabetic foot ulcers, pressure sores, and burns. In addition to its antimicrobial properties, Flaminal supports autolytic debridement and maintains an optimal moisture balance to facilitate the healing process.
- Brand names
- FlaminalFlaminal HydroFlaminal Forte
- Other names
- Enzyme alginogel
02
Targets
MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)LPO (Lactoperoxidase)
Beyond the preview
Go deeper on Flaminal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flaminal.